STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance. Li T, Zhang W, Niu M, Wu Y, et al. Front Immunol 2024;15:1342647.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li T, Zhang W, Niu M, Wu Y, et al. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance. Front Immunol 2024;15:1342647.
PMID: 38550593